aluates Reports

$ 0.0

Automative

Global Biosimilar Drug Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: March 2025

Report Code: QYRE-Auto-16A2554

Global Biosimilar Drug Market Insights and Forecast to 2028

BUY CHAPTERS

Global Biosimilar Drug Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-16A2554

Report

March 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Eli Lilly

CP Guojian Pharma

Biotech Pharma

Celgen Pharma

Henlius

Sandoz Inc

Changchun High Tech

Innovent

Biosimilar Drug Sales Market

The global Biosimilar Drug market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product"s patent expires.

In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.

East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.

In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.

The global Biosimilar Drug market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Scope of Biosimilar Drug Sales Market Report

Report Metric	Details
Report Name	Biosimilar Drug Sales Market
By Type: (Dominant Segment vs High-Margin Innovation)	Injection Tablets Other Types
By Application: (Core Demand Driver vs Emerging Opportunity)	Ankylosing Spondylitis Tumor Rheumatoid Arthrtis Cardiovascular Other Application
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	CP Guojian Pharma, Biotech Pharma, Celgen Pharma, Henlius, Amgen, Eli Lilly, Sandoz, Changchun High Tech, Innovent
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Biosimilar Drug market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Tablets in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Tumor in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Injection dominance in Europe vs. Tablets demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

FAQ for this report

What is the market share of major companies in Biosimilar Drug Sales Market?

Ans: Global top three manufacturers hold a share over 70%.

What is the Biosimilar Drug Sales Market share by type?

Ans: In terms of product, Tablets is the largest segment, with a share over 65%.

Who are the main players in the Biosimilar Drug Sales Market report?

Ans: The main players in the Biosimilar Drug Sales Market are CP Guojian Pharma, Biotech Pharma, Celgen Pharma, Henlius, Amgen, Eli Lilly, Sandoz, Changchun High Tech, Innovent

What are the Application segmentation covered in the Biosimilar Drug Sales Market report?

Ans: The Applications covered in the Biosimilar Drug Sales Market report are Ankylosing Spondylitis, Tumor, Rheumatoid Arthrtis, Cardiovascular, Other Application

What are the Type segmentation covered in the Biosimilar Drug Sales Market report?

Ans: The Types covered in the Biosimilar Drug Sales Market report are Injection, Tablets, Other Types

Recommended Reports

Biosimilars & Biologics

Biologic Drug Markets

Rheumatology & Autoimmune

Market trends :

Topic	Trends
Global	biosimilar drug market growth is driven by patent expirations, regulatory support, and increased adoption in chronic disease management, with tablets leading product demand and ankylosing spondylitis as the primary application segment.
Type	Injection - injection biosimilars see robust demand in europe due to established clinical protocols and patient preference. Tablets - tablets dominate global biosimilar sales, driven by ease of administration and patient adherence, especially in mea and china. Other Types - other types of biosimilars gain traction as niche therapies address unmet clinical needs.
Application	Ankylosing Spondylitis - ankylosing spondylitis remains the largest application for biosimilars, supported by high prevalence and treatment adoption. Tumor - biosimilars for tumor applications experience rapid uptake in india and apac, reflecting oncology market expansion. Rheumatoid Arthrtis - rheumatoid arthritis biosimilars benefit from increased diagnosis rates and expanded reimbursement policies. Cardiovascular - cardiovascular biosimilars emerge as an opportunity segment with growing clinical acceptance. Other Application - other applications for biosimilars expand as new indications receive regulatory approvals.
Company	CP Guojian Pharma - cp guojian pharma maintains a leading position in china's biosimilar market, leveraging regional dominance and portfolio expansion. Biotech Pharma - biotech pharma capitalizes on strong demand for biosimilars in east china, focusing on recombinant protein products. Celgen Pharma - celgen pharma strengthens its market share through targeted biosimilar launches for autoimmune diseases. Henlius - henlius expands its biosimilar offerings in apac, emphasizing regulatory compliance and product innovation. Amgen - amgen accelerates biosimilar commercialization in global markets, focusing on oncology and autoimmune indications. Eli Lilly - eli lilly enhances its biosimilar pipeline with a focus on chronic disease therapies and emerging markets. Sandoz - sandoz leverages global distribution networks to increase biosimilar penetration, particularly in emea and north america. Changchun High Tech - changchun high tech expands biosimilar production capacity to meet rising demand in china. Innovent - innovent targets high-growth segments in oncology biosimilars, driving regional expansion in apac.
Region	North America - north america sees increased biosimilar adoption following regulatory clarity and payer support. EMEA - emea region leads in biosimilar market maturity, driven by favorable policies and healthcare cost containment. APAC - apac biosimilar market grows rapidly, led by china's large-scale manufacturing and rising healthcare demand. LATAM - latam biosimilar uptake accelerates as governments promote access to affordable biologics.

1 Market Overview

1.1 Biosimilar Drug Product Scope

1.2 Biosimilar Drug by Type

1.2.1 Global Biosimilar Drug Sales by Type (2020 & 2024 & 2031)

1.2.2 Injection

1.2.3 Tablets

1.2.4 Other Types

1.3 Biosimilar Drug by Application

1.3.1 Global Biosimilar Drug Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Ankylosing Spondylitis

1.3.3 Tumor

1.3.4 Rheumatoid Arthrtis

1.3.5 Cardiovascular

1.3.6 Other Application

1.4 Global Biosimilar Drug Market Estimates and Forecasts (2020-2031)

1.4.1 Global Biosimilar Drug Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Biosimilar Drug Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Biosimilar Drug Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Biosimilar Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Biosimilar Drug Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Biosimilar Drug Sales Market Share by Region (2020-2025)

2.2.2 Global Biosimilar Drug Revenue Market Share by Region (2020-2025)

2.3 Global Biosimilar Drug Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Biosimilar Drug Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Biosimilar Drug Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Biosimilar Drug Market Size and Prospective (2020-2031)

2.4.2 Europe Biosimilar Drug Market Size and Prospective (2020-2031)

2.4.3 China Biosimilar Drug Market Size and Prospective (2020-2031)

2.4.4 Japan Biosimilar Drug Market Size and Prospective (2020-2031)

2.4.5 Singapore Biosimilar Drug Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Biosimilar Drug Historic Market Review by Type (2020-2025)

3.1.1 Global Biosimilar Drug Sales by Type (2020-2025)

3.1.2 Global Biosimilar Drug Revenue by Type (2020-2025)

3.1.3 Global Biosimilar Drug Price by Type (2020-2025)

3.2 Global Biosimilar Drug Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Biosimilar Drug Sales Forecast by Type (2026-2031)

3.2.2 Global Biosimilar Drug Revenue Forecast by Type (2026-2031)

3.2.3 Global Biosimilar Drug Price Forecast by Type (2026-2031)

3.3 Different Types Biosimilar Drug Representative Players

4 Global Market Size by Application

4.1 Global Biosimilar Drug Historic Market Review by Application (2020-2025)

4.1.1 Global Biosimilar Drug Sales by Application (2020-2025)

4.1.2 Global Biosimilar Drug Revenue by Application (2020-2025)

4.1.3 Global Biosimilar Drug Price by Application (2020-2025)

4.2 Global Biosimilar Drug Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Biosimilar Drug Sales Forecast by Application (2026-2031)

4.2.2 Global Biosimilar Drug Revenue Forecast by Application (2026-2031)

4.2.3 Global Biosimilar Drug Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Biosimilar Drug Application

5 Competition Landscape by Players

5.1 Global Biosimilar Drug Sales by Players (2020-2025)

5.2 Global Top Biosimilar Drug Players by Revenue (2020-2025)

5.3 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2024)

5.4 Global Biosimilar Drug Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Biosimilar Drug, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Biosimilar Drug, Product Type & Application

5.7 Global Key Manufacturers of Biosimilar Drug, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Biosimilar Drug Sales by Company

6.1.1.1 North America Biosimilar Drug Sales by Company (2020-2025)

6.1.1.2 North America Biosimilar Drug Revenue by Company (2020-2025)

6.1.2 North America Biosimilar Drug Sales Breakdown by Type (2020-2025)

6.1.3 North America Biosimilar Drug Sales Breakdown by Application (2020-2025)

6.1.4 North America Biosimilar Drug Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Biosimilar Drug Sales by Company

6.2.1.1 Europe Biosimilar Drug Sales by Company (2020-2025)

6.2.1.2 Europe Biosimilar Drug Revenue by Company (2020-2025)

6.2.2 Europe Biosimilar Drug Sales Breakdown by Type (2020-2025)

6.2.3 Europe Biosimilar Drug Sales Breakdown by Application (2020-2025)

6.2.4 Europe Biosimilar Drug Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Biosimilar Drug Sales by Company

6.3.1.1 China Biosimilar Drug Sales by Company (2020-2025)

6.3.1.2 China Biosimilar Drug Revenue by Company (2020-2025)

6.3.2 China Biosimilar Drug Sales Breakdown by Type (2020-2025)

6.3.3 China Biosimilar Drug Sales Breakdown by Application (2020-2025)

6.3.4 China Biosimilar Drug Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Biosimilar Drug Sales by Company

6.4.1.1 Japan Biosimilar Drug Sales by Company (2020-2025)

6.4.1.2 Japan Biosimilar Drug Revenue by Company (2020-2025)

6.4.2 Japan Biosimilar Drug Sales Breakdown by Type (2020-2025)

6.4.3 Japan Biosimilar Drug Sales Breakdown by Application (2020-2025)

6.4.4 Japan Biosimilar Drug Major Customer

6.4.5 Japan Market Trend and Opportunities

6.5 Singapore Market: Players, Segments, Downstream and Major Customers

6.5.1 Singapore Biosimilar Drug Sales by Company

6.5.1.1 Singapore Biosimilar Drug Sales by Company (2020-2025)

6.5.1.2 Singapore Biosimilar Drug Revenue by Company (2020-2025)

6.5.2 Singapore Biosimilar Drug Sales Breakdown by Type (2020-2025)

6.5.3 Singapore Biosimilar Drug Sales Breakdown by Application (2020-2025)

6.5.4 Singapore Biosimilar Drug Major Customer

6.5.5 Singapore Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 CP Guojian Pharma

7.1.1 CP Guojian Pharma Company Information

7.1.2 CP Guojian Pharma Business Overview

7.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)

7.1.4 CP Guojian Pharma Biosimilar Drug Products Offered

7.1.5 CP Guojian Pharma Recent Development

7.2 Biotech Pharma

7.2.1 Biotech Pharma Company Information

7.2.2 Biotech Pharma Business Overview

7.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Biotech Pharma Biosimilar Drug Products Offered

7.2.5 Biotech Pharma Recent Development

7.3 Celgen Pharma

7.3.1 Celgen Pharma Company Information

7.3.2 Celgen Pharma Business Overview

7.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Celgen Pharma Biosimilar Drug Products Offered

7.3.5 Celgen Pharma Recent Development

7.4 Henlius

7.4.1 Henlius Company Information

7.4.2 Henlius Business Overview

7.4.3 Henlius Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Henlius Biosimilar Drug Products Offered

7.4.5 Henlius Recent Development

7.5 Amgen

7.5.1 Amgen Company Information

7.5.2 Amgen Business Overview

7.5.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Amgen Biosimilar Drug Products Offered

7.5.5 Amgen Recent Development

7.6 Eli Lilly

7.6.1 Eli Lilly Company Information

7.6.2 Eli Lilly Business Overview

7.6.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Eli Lilly Biosimilar Drug Products Offered

7.6.5 Eli Lilly Recent Development

7.7 Sandoz

7.7.1 Sandoz Company Information

7.7.2 Sandoz Business Overview

7.7.3 Sandoz Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Sandoz Biosimilar Drug Products Offered

7.7.5 Sandoz Recent Development

7.8 Changchun High Tech

7.8.1 Changchun High Tech Company Information

7.8.2 Changchun High Tech Business Overview

7.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Changchun High Tech Biosimilar Drug Products Offered

7.8.5 Changchun High Tech Recent Development

7.9 Innovent

7.9.1 Innovent Company Information

7.9.2 Innovent Business Overview

7.9.3 Innovent Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Innovent Biosimilar Drug Products Offered

7.9.5 Innovent Recent Development

8 Biosimilar Drug Manufacturing Cost Analysis

8.1 Biosimilar Drug Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Biosimilar Drug

8.4 Biosimilar Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Biosimilar Drug Distributors List

9.3 Biosimilar Drug Customers

10 Biosimilar Drug Market Dynamics

10.1 Biosimilar Drug Industry Trends

10.2 Biosimilar Drug Market Drivers

10.3 Biosimilar Drug Market Challenges

10.4 Biosimilar Drug Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

Eli Lilly

CP Guojian Pharma

Biotech Pharma

Celgen Pharma

Henlius

Sandoz Inc

Changchun High Tech

Innovent

List of Tables

Table 1. Global Biosimilar Drug Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Biosimilar Drug Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Biosimilar Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Biosimilar Drug Sales (K Dose) by Region (2020-2025)

Table 5. Global Biosimilar Drug Sales Market Share by Region (2020-2025)

Table 6. Global Biosimilar Drug Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Biosimilar Drug Revenue Share by Region (2020-2025)

Table 8. Global Biosimilar Drug Sales (K Dose) Forecast by Region (2026-2031)

Table 9. Global Biosimilar Drug Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Biosimilar Drug Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Biosimilar Drug Revenue Share Forecast by Region (2026-2031)

Table 12. Global Biosimilar Drug Sales by Type (K Dose) & (2020-2025)

Table 13. Global Biosimilar Drug Sales Share by Type (2020-2025)

Table 14. Global Biosimilar Drug Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Biosimilar Drug Price by Type (USD/Dose) & (2020-2025)

Table 16. Global Biosimilar Drug Sales by Type (K Dose) & (2026-2031)

Table 17. Global Biosimilar Drug Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Biosimilar Drug Price by Type (USD/Dose) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Biosimilar Drug Sales by Application (K Dose) & (2020-2025)

Table 21. Global Biosimilar Drug Sales Share by Application (2020-2025)

Table 22. Global Biosimilar Drug Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Biosimilar Drug Price by Application (USD/Dose) & (2020-2025)

Table 24. Global Biosimilar Drug Sales by Application (K Dose) & (2026-2031)

Table 25. Global Biosimilar Drug Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Biosimilar Drug Price by Application (USD/Dose) & (2026-2031)

Table 27. New Sources of Growth in Biosimilar Drug Application

Table 28. Global Biosimilar Drug Sales by Company (K Dose) & (2020-2025)

Table 29. Global Biosimilar Drug Sales Share by Company (2020-2025)

Table 30. Global Biosimilar Drug Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Biosimilar Drug Revenue Share by Company (2020-2025)

Table 32. Global Biosimilar Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2024)

Table 33. Global Market Biosimilar Drug Average Price by Company (USD/Dose) & (2020-2025)

Table 34. Global Key Manufacturers of Biosimilar Drug, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Biosimilar Drug, Product Type & Application

Table 36. Global Key Manufacturers of Biosimilar Drug, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Biosimilar Drug Sales by Company (2020-2025) & (K Dose)

Table 39. North America Biosimilar Drug Sales Market Share by Company (2020-2025)

Table 40. North America Biosimilar Drug Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Biosimilar Drug Revenue Market Share by Company (2020-2025)

Table 42. North America Biosimilar Drug Sales by Type (2020-2025) & (K Dose)

Table 43. North America Biosimilar Drug Sales Market Share by Type (2020-2025)

Table 44. North America Biosimilar Drug Sales by Application (2020-2025) & (K Dose)

Table 45. North America Biosimilar Drug Sales Market Share by Application (2020-2025)

Table 46. Europe Biosimilar Drug Sales by Company (2020-2025) & (K Dose)

Table 47. Europe Biosimilar Drug Sales Market Share by Company (2020-2025)

Table 48. Europe Biosimilar Drug Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Biosimilar Drug Revenue Market Share by Company (2020-2025)

Table 50. Europe Biosimilar Drug Sales by Type (2020-2025) & (K Dose)

Table 51. Europe Biosimilar Drug Sales Market Share by Type (2020-2025)

Table 52. Europe Biosimilar Drug Sales by Application (2020-2025) & (K Dose)

Table 53. Europe Biosimilar Drug Sales Market Share by Application (2020-2025)

Table 54. China Biosimilar Drug Sales by Company (2020-2025) & (K Dose)

Table 55. China Biosimilar Drug Sales Market Share by Company (2020-2025)

Table 56. China Biosimilar Drug Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Biosimilar Drug Revenue Market Share by Company (2020-2025)

Table 58. China Biosimilar Drug Sales by Type (2020-2025) & (K Dose)

Table 59. China Biosimilar Drug Sales Market Share by Type (2020-2025)

Table 60. China Biosimilar Drug Sales by Application (2020-2025) & (K Dose)

Table 61. China Biosimilar Drug Sales Market Share by Application (2020-2025)

Table 62. Japan Biosimilar Drug Sales by Company (2020-2025) & (K Dose)

Table 63. Japan Biosimilar Drug Sales Market Share by Company (2020-2025)

Table 64. Japan Biosimilar Drug Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Biosimilar Drug Revenue Market Share by Company (2020-2025)

Table 66. Japan Biosimilar Drug Sales by Type (2020-2025) & (K Dose)

Table 67. Japan Biosimilar Drug Sales Market Share by Type (2020-2025)

Table 68. Japan Biosimilar Drug Sales by Application (2020-2025) & (K Dose)

Table 69. Japan Biosimilar Drug Sales Market Share by Application (2020-2025)

Table 70. Singapore Biosimilar Drug Sales by Company (2020-2025) & (K Dose)

Table 71. Singapore Biosimilar Drug Sales Market Share by Company (2020-2025)

Table 72. Singapore Biosimilar Drug Revenue by Company (2020-2025) & (US$ Million)

Table 73. Singapore Biosimilar Drug Revenue Market Share by Company (2020-2025)

Table 74. Singapore Biosimilar Drug Sales by Type (2020-2025) & (K Dose)

Table 75. Singapore Biosimilar Drug Sales Market Share by Type (2020-2025)

Table 76. Singapore Biosimilar Drug Sales by Application (2020-2025) & (K Dose)

Table 77. Singapore Biosimilar Drug Sales Market Share by Application (2020-2025)

Table 78. CP Guojian Pharma Company Information

Table 79. CP Guojian Pharma Description and Business Overview

Table 80. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 81. CP Guojian Pharma Biosimilar Drug Product

Table 82. CP Guojian Pharma Recent Development

Table 83. Biotech Pharma Company Information

Table 84. Biotech Pharma Description and Business Overview

Table 85. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 86. Biotech Pharma Biosimilar Drug Product

Table 87. Biotech Pharma Recent Development

Table 88. Celgen Pharma Company Information

Table 89. Celgen Pharma Description and Business Overview

Table 90. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 91. Celgen Pharma Biosimilar Drug Product

Table 92. Celgen Pharma Recent Development

Table 93. Henlius Company Information

Table 94. Henlius Description and Business Overview

Table 95. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 96. Henlius Biosimilar Drug Product

Table 97. Henlius Recent Development

Table 98. Amgen Company Information

Table 99. Amgen Description and Business Overview

Table 100. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 101. Amgen Biosimilar Drug Product

Table 102. Amgen Recent Development

Table 103. Eli Lilly Company Information

Table 104. Eli Lilly Description and Business Overview

Table 105. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 106. Eli Lilly Biosimilar Drug Product

Table 107. Eli Lilly Recent Development

Table 108. Sandoz Company Information

Table 109. Sandoz Description and Business Overview

Table 110. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 111. Sandoz Biosimilar Drug Product

Table 112. Sandoz Recent Development

Table 113. Changchun High Tech Company Information

Table 114. Changchun High Tech Description and Business Overview

Table 115. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 116. Changchun High Tech Biosimilar Drug Product

Table 117. Changchun High Tech Recent Development

Table 118. Innovent Company Information

Table 119. Innovent Description and Business Overview

Table 120. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 121. Innovent Biosimilar Drug Product

Table 122. Innovent Recent Development

Table 123. Production Base and Market Concentration Rate of Raw Material

Table 124. Key Suppliers of Raw Materials

Table 125. Biosimilar Drug Distributors List

Table 126. Biosimilar Drug Customers List

Table 127. Biosimilar Drug Market Trends

Table 128. Biosimilar Drug Market Drivers

Table 129. Biosimilar Drug Market Challenges

Table 130. Biosimilar Drug Market Restraints

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Biosimilar Drug Product Picture

Figure 2. Global Biosimilar Drug Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Biosimilar Drug Sales Market Share by Type in 2024 & 2031

Figure 4. Injection Product Picture

Figure 5. Tablets Product Picture

Figure 6. Other Types Product Picture

Figure 7. Global Biosimilar Drug Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 8. Global Biosimilar Drug Sales Market Share by Application in 2024 & 2031

Figure 9. Ankylosing Spondylitis Examples

Figure 10. Tumor Examples

Figure 11. Rheumatoid Arthrtis Examples

Figure 12. Cardiovascular Examples

Figure 13. Other Application Examples

Figure 14. Global Biosimilar Drug Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Biosimilar Drug Sales Growth Rate (2020-2031) & (US$ Million)

Figure 16. Global Biosimilar Drug Sales (K Dose) Growth Rate (2020-2031)

Figure 17. Global Biosimilar Drug Price Trends Growth Rate (2020-2031) & (USD/Dose)

Figure 18. Biosimilar Drug Report Years Considered

Figure 19. Global Market Biosimilar Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 20. Global Biosimilar Drug Revenue Market Share by Region: 2020 VS 2024

Figure 21. North America Biosimilar Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. North America Biosimilar Drug Sales (K Dose) Growth Rate (2020-2031)

Figure 23. Europe Biosimilar Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Europe Biosimilar Drug Sales (K Dose) Growth Rate (2020-2031)

Figure 25. China Biosimilar Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. China Biosimilar Drug Sales (K Dose) Growth Rate (2020-2031)

Figure 27. Japan Biosimilar Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 28. Japan Biosimilar Drug Sales (K Dose) Growth Rate (2020-2031)

Figure 29. Singapore Biosimilar Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 30. Singapore Biosimilar Drug Sales (K Dose) Growth Rate (2020-2031)

Figure 31. Global Biosimilar Drug Revenue Share by Type (2020-2025)

Figure 32. Global Biosimilar Drug Sales Share by Type (2026-2031)

Figure 33. Global Biosimilar Drug Revenue Share by Type (2026-2031)

Figure 34. Global Biosimilar Drug Revenue Share by Application (2020-2025)

Figure 35. Global Biosimilar Drug Revenue Growth Rate by Application in 2020 & 2024

Figure 36. Global Biosimilar Drug Sales Share by Application (2026-2031)

Figure 37. Global Biosimilar Drug Revenue Share by Application (2026-2031)

Figure 38. Global Biosimilar Drug Sales Share by Company (2024)

Figure 39. Global Biosimilar Drug Revenue Share by Company (2024)

Figure 40. Global 5 Largest Biosimilar Drug Players Market Share by Revenue in Biosimilar Drug: 2020 & 2024

Figure 41. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 42. Manufacturing Cost Structure of Biosimilar Drug

Figure 43. Manufacturing Process Analysis of Biosimilar Drug

Figure 44. Biosimilar Drug Industrial Chain

Figure 45. Channels of Distribution (Direct Vs Distribution)

Figure 46. Distributors Profiles

Figure 47. Bottom-up and Top-down Approaches for This Report

Figure 48. Data Triangulation

Figure 49. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Bevacizumab Biosimilar Market

Glycosylated Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cetuximab Biosimilar Market Research Report 2025

Global Filgrastim and Biosimilars Market Research Report 2024

Generic and Biosimilar Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Glycosylated Proteins Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Trastuzumab Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Adalimumab Infliximab And Etanercept Biosimilars Market Research Report 2024

Biosimilar of Remicade Market

Global Herceptin Biosimilar Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions